← Evidence map

ArticleJournal of clinical pharmacology2016

More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter-Mediated Clearances.

Ariane Emami Riedmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27385171